Anti-Anginal Efficacy of Zibotentan in the Coronary Slow-Flow Phenomenon.

Sivabaskari PasupathyRosanna TavellaChristopher ZeitzSuzanne Melissa EdwardsMatthew WorthleyMargaret ArstallJohn F Beltrame

Published in: Journal of clinical medicine (2024)

Zibotentan improved the frequency of spontaneous angina episodes and reduced sublingual nitrate consumption in patients unresponsive to standard anti-anginal therapy.

Keyphrases

end stage renal disease
coronary artery disease
coronary artery
newly diagnosed
ejection fraction
chronic kidney disease
nitric oxide
peritoneal dialysis
prognostic factors
patient reported outcomes
mesenchymal stem cells
atrial fibrillation
left ventricular
bone marrow
acute coronary syndrome
smoking cessation